期刊文献+

结核分枝杆菌潜伏感染豚鼠模型的建立和验证 被引量:8

Establishment and validation of a guinea pig model of latent Mycobacterium tuberculosis infection
原文传递
导出
摘要 目的:建立结核分枝杆菌(M ycobacterium tuberclu osis,Mtb)潜伏感染治疗用疫苗的豚鼠评价模型。方法豚鼠皮下攻毒5.0×103 CFU Mtb,于不同时间点用0.5μg重组结核杆菌ESAT6-CFP10蛋白对豚鼠皮试,观察皮试阳转情况。攻毒2周后,模型组豚鼠采用5 mg异烟肼灌胃治疗,每周3次,持续4周;对照组豚鼠不做化疗。在Mtb感染后的第6周,分别取未经异烟肼治疗的豚鼠和经异烟肼治疗的豚鼠解剖,比较豚鼠的肝、脾和肺的脏器综合病变指数以及脾活菌数( log10 CFU)。根据上述结果建立豚鼠的潜伏感染模型,并用两个参考疫苗对该模型进行验证。结果豚鼠攻毒Mtb 2周后,EC皮试反应全部转阳,皮试反应大小为(19.9±3.0) mm。模型组豚鼠经4周异烟肼治疗后,脏器综合病变指数为0,脾未分离出活菌数。对照组豚鼠不经化疗,脏器综合病变指数为38.8±16.5,脾活菌数为(5.1±0.3)log10 CFU。停药后,模型组豚鼠结核病自然复发,在两次参考疫苗的验证中,脏器综合病变指数分别为48.5±23.9和51.30±23.41,脾活菌数分别为(4.5±1.3)和(4.2±1.1) log10 CFU,肺部活菌数分别为(4.1±1.2)和(3.4±1.3) log10 CFU。结论 Mtb攻毒豚鼠后,异烟肼化疗可抑制Mtb增殖,成功建立豚鼠的Mtb潜伏感染模型。该模型重复性好,可用于潜伏感染治疗用疫苗的评价。 Objective To establish a guinea pig model of latent Mycobacterium tuberculosis infec-tion for evaluating the effects of therapeutic vaccines .Methods Guinea pigs were subcutaneously inocula-ted with 5.0×103 CFU Mtb.The skin test was performed with 0.5μg recombinant ESAT6-CFP10 protein to detect positive conversion rates at different time points .Two weeks after Mtb inoculation , guinea pigs in model group received 5 mg isoniazid treatment ( three times a week for four weeks ) by oral gavage , while those in control group received normal saline .At the sixth week after Mtb infection , guinea pigs with and without isoniazid treatment were dissected for pathology examination .The pathological scores of liver , spleen and lung, as well as bacteria loads in spleen were compared between two groups .The established guinea pig model of latent infection was then validated by testing two reference vaccines ( AEC/BC02 and AEC/BC03 ) . Results Two weeks after Mtb inoculation , all guinea pigs showed positive EC skin test with induration area of (19.9±3.0) mm.Upon four weeks of isoniazid treatment , the guinea pigs in model group showed no pathological changes with zero scores in the examined organs .No bacterium was detected in spleen of ani-mals from model group.However, the total pathological score was 38.8±16.5 and bacteria load in spleen was (5.1±0.3) Log10 CFU with the guinea pigs from control group .Natural recurrence of tuberculosis in model group was observed after drug withdrawal .The total pathological scores were 48.5±23.9 and 51.3± 23.41.The bacterial loads in spleen were (4.5±1.3) and (4.2±1.1) Log10 CFU and bacterial loads in lung were (4.1±1.2) and (3.4±1.3) Log10 CFU respectively as verified with reference vaccines of AEC /BC02 and AEC/BC03.Conclusion Isoniazid treatment inhibited the proliferation of inoculated Mtb in guinea pigs.A guinea pig model of latent Mycobacterium tuberculosis infection is successfully established with an advantage of good repeatability .Therefore, it can be used to evaluate the effects of therapeutic vaccines on latent Mycobacterium tuberculosis infection.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2013年第12期900-905,共6页 Chinese Journal of Microbiology and Immunology
关键词 结核分枝杆菌 潜伏感染 动物模型 豚鼠 结核疫苗 Mycobacterium tuberculosis Latent infection Animal model Guinea pig TB vaccine
  • 相关文献

参考文献23

  • 1Ottenhoff TH,Kaufmann SH. Vaccines against tuberculosis:where are we and where do we need to go[J].{H}PLoS Pathogens,2012,(05):e1002607.
  • 2王森,张文宏.潜伏性结核感染的诊治进展[J].微生物与感染,2008,3(4):234-237. 被引量:18
  • 3Stop TB Partnership. Tuberculosis vaccine candidates[OL].http://www.stoptb.org/wg/new_vaccines/docu-ments.asp,2013.
  • 4Derrick SC,Perera LP,Dheenadhayalan V. The safety of post-exposure vaccination of mice infected with Myocbacterium tu-berculosi s[J].{H}VACCINE,2008,(48):6092-6098.
  • 5黎友伦,王国治,罗永艾.结核分枝杆菌潜伏感染动物模型及评价[J].中华结核和呼吸杂志,2005,28(8):552-554. 被引量:17
  • 6Dye C,Fine PEM. A major event for new tuberculosis vaccines[J].{H}LANCET,2013,(9871):972-974.
  • 7Aagaard C,Hoang T,Dietrich J. A multistage tuberculosis vaccine that confers efficient protection before and after exposure[J].{H}Nature Medicine,2011,(02):189-194.
  • 8Tameris MD,Hatherill M,Landry BS. Safety and efficacy of MVA85A,a new tuberculosis vaccine,in infants previously vacci-nated with BCG:a randomised,placebo-controlled phase 2b trial[J].{H}LANCET,2013,(9871):1021-1028.
  • 9Shi C,Shi J,Xu Z. A review of murine models of latent tuberculo-sis infection[J].{H}SCANDINAVIAN Journal OF INFECTIOUS DISEASES,2011,(11-12):848-856.
  • 10Grover A,Troudt J,Arnett K. Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis[J].{H}Tuberculosis(Edinb),2012,(01):105-111.

二级参考文献75

  • 1黎友伦,王国治,罗永艾.结核分枝杆菌潜伏感染动物模型及评价[J].中华结核和呼吸杂志,2005,28(8):552-554. 被引量:17
  • 2刘剑君,幺鸿雁.我国结核病的流行现状和防治对策[J].预防医学论坛,2006,12(5):638-640. 被引量:54
  • 3World Health Organization. Gobal tuberculosis control: Surveillance, planning, financing. WHO Report 2005. Geneva, 2005,349
  • 4American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med , 2000, 161:221 -247
  • 5Centers for Disease Control and Prevention. Controlling tuberculosis in the United States :recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR,2005,54 : 1 - 81
  • 6Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med, 2004,350:2060 - 2067
  • 7Haley CA, Cain KP, Yu C, et al. Risk-based screening for latent tuberculosis infection. Southern Med J, 2008, 101 : 142 - 149
  • 8Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis. MMWR, 2000, 49:1-54
  • 9Ozekinci T, Ozbek E. Comparison of tuberculin skin test and a specific T-cell-based test, T-Spot. TB, for the diagnosis of latent tuberculosis infection. J Int Med Res, 2007, 35:696 - 703
  • 10Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest, 2007, 131:1898 - 1906

共引文献47

同被引文献65

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部